Alzheimer’s disease community from our Head of Research and Development, Alfred Sandrock, M.D., Ph.D.
The Pharma Data
JULY 22, 2021
We believe patients, family members and physicians deserve the facts about the therapy and the process by which it was approved so they may make informed decisions. That was exemplified at its best with the COVID-19 vaccine development. ADUHELM is the first Alzheimer’s treatment approved since 2003. MS is another good example.
Let's personalize your content